Cognitive Dysfunction and Glucagon-like Peptide-1 Agonists

Clinical trial NCT02423824 · COMPLETED

Trial details

NCT number: NCT02423824
Sponsor: University Health Network, Toronto
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bipolar Disorder Major Depressive Disorder

Start date: 2015-05-01
Primary completion: 2016-04-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.